April Anderson+FollowGame-Changer for Tough Lymphomas?Just read about a new treatment combo that could seriously boost survival for people with aggressive T- and NK-cell lymphomas. Researchers found that using small-molecule inhibitors first, then epigenetic modifiers, worked way better than old-school chemo for those who relapsed. The difference was especially huge for high-risk patients! It’s wild how switching up the order of meds could make such a big impact. Could this be the new standard for tough-to-treat blood cancers? #CancerResearch #Lymphoma #MedicalBreakthrough #Oncology #HealthNews #Health20Share
Allison Bauer+FollowGame-Changer for Lymphoma Treatment!Big news for mantle cell lymphoma patients: the EU just approved a new combo therapy with acalabrutinib, bendamustine, and rituximab as a first-line treatment! This means older patients who can’t get stem cell transplants now have a shot at better outcomes—16+ months longer progression-free survival compared to standard chemo. The trial showed higher response rates too. It’s not a cure, but it’s a much-needed win for a tough cancer. Science for the win! #Lymphoma #CancerResearch #MedicalBreakthrough #HealthcareNews #Health313Share
